 |
| |
| |
| Studying hallmarks of cancer |
| Find out the most relevant markers and tools to study the important processes that give rise to cancer cells. |
| |
|
|
| |
| |
|
|
|
|
|
| |
| Cancer metabolism pathway |
| Learn the essential enzyme and protein alterations of cancer cell metabolism, from glycolysis to transcriptional regulation. |
| |
|
|
|
|
|
| |
|
|
| |
| Immunoprecipitation protocol |
| We’ve laid out the IP procedure with reagents and a table to help you choose the correct protein beads. |
| |
|
|
|
|
| |
|
|
| |
| Online training |
| Sign up for our free, online training programmes and receive the support you need to develop your skills |
| |
|
|
|
|
| |
|
|
| |
| Tackling Parkinson’s |
| Complex research demands the best reagents. With MJFF, we’ve developed monoclonal antibodies against key Parkinson's targets like LRRK2 and RAB10. |
| |
|
|
|
|
| |
|
|
| |
| The EMT toolbox |
| Find out what tools you need to research epithelial to mesenchymal transition in neuroscience and cancer. |
| |
|
|
|
|
| |
|
|
| |
| Diagnostic variation |
| We take a look at the source of the variability seen in PD1/PD-L1 antibody-based diagnostics including protocol sensitivity and epitope binding. |
| |
|
|
|
|
| |
No hay comentarios:
Publicar un comentario